首页 > 市场调查报告书 > 製药

基因治疗学和RNAi

基因合成市场规模、份额和成长分析（按方法、服务、应用、最终用途和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1900364

基因合成市场规模、份额和成长分析（按方法、服务、应用、最终用途和地区划分）－2026-2033年产业预测

Gene Synthesis Market Size, Share, and Growth Analysis, By Method (Solid-Phase Synthesis, Chip-Based Synthesis), By Service (Antibody DNA Synthesis), By Application, By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，基因合成市场规模将达到 23.7 亿美元，到 2025 年将达到 27.5 亿美元，到 2033 年将达到 90.8 亿美元，在预测期（2026-2033 年）内，复合年增长率将达到 16.1%。

基因合成市场正经历显着成长，这主要得益于政府的支持性政策和对合成生物学研究投入的增加。特别是新冠疫情，已促使公共和私人管道投入约80亿美元。这场危机刺激了基因合成领域的研究，而用于改进诊断的合成SARS-CoV-2基因片段等创新应用正在推动收入成长。此外，合成DNA技术的进步也为应对新出现的病毒威胁提供了解决方案。同时，在生物技术和製药领域，对标靶治疗的日益重视为基因合成公司带来了盈利的机会。然而，由于熟练专业人才短缺，市场面临挑战，促使各公司与教育机构合作开展培训倡议，以培养必要的人才。

基因合成市场驱动因素

基因合成市场的发展主要得益于分子生物学、基因工程、药物研发和合成生物学等多个领域的显着贡献。这项技术能够深入阐明基因功能，建构基因改造生物，并开发创新疗法。它也有助于建构新型生物系统，拓展科学研究和应用的可能性。随着基因合成技术在研发活动中的效用不断扩展，其日益增长的重要性推动了市场需求的成长，这体现了其在推动各种生物技术和医学创新方面发挥的关键作用。

基因合成市场限制因素

基因合成市场面临许多挑战，其中最主要的挑战在于合成遗传物质可能被滥用，导致有害病原体和微生物的产生，而这引发了伦理方面的担忧。这些伦理问题要求建立健全的法规结构，以降低风险并确保产业在既定的安全标准内运作。然而，这些监管法规的严格性可能会限制市场成长，尤其是在各种应用所需的核准和许可流程方面。因此，虽然遵守监管规定对于维护安全和伦理标准至关重要，但同时也可能限制基因合成领域的创新和发展。

基因合成市场趋势

基因合成市场正经历显着成长，这主要得益于对基因编辑和基因治疗创新（尤其是CRISPR-Cas9等先进技术的应用）日益增长的需求。随着研究人员和生技公司致力于开发精准的基因修饰方法，客製化DNA构建体的需求变得至关重要。这一趋势凸显了基因合成在推动基因治疗和个人化医疗突破方面的重要作用。此外，人们对这些先进技术的日益关注也加剧了基因合成产业的竞争，促使各公司不断提升服务水准并创新製程。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Thermo Fisher Scientific Inc.（GeneArt）
GenScript Biotech Corporation
Eurofins Genomics
Integrated DNA Technologies（IDT）
Twist Bioscience
ATUM
Bio Basic Inc.
SBS Genetech Co. Ltd
Azenta Life Sciences
OriGene Technologies Inc.
Bioneer Corporation
Genewiz
Blue Heron Biotech
Creative Biogene
SGI-DNA

结论与建议

简介目录

Product Code: SQMIG35H2240

Gene Synthesis Market size was valued at USD 2.37 Billion in 2024 and is poised to grow from USD 2.75 Billion in 2025 to USD 9.08 Billion by 2033, growing at a CAGR of 16.1% during the forecast period (2026-2033).

The gene synthesis market is witnessing significant growth driven by favorable government policies and increasing investment in synthetic biology research. The sector has attracted approximately USD 8.0 billion from public and private funding, particularly spurred by opportunities arising from the COVID-19 pandemic. This crisis has catalyzed exploration in gene synthesis, enhancing revenue potential as researchers pursue innovative applications, such as synthetic SARS-CoV-2 gene segments for diagnostic advancements. Additionally, breakthroughs in synthetic DNA technology offer solutions to emerging viral threats. Meanwhile, the biotechnology and pharmaceutical sectors are increasingly focusing on targeted therapies, indicating profitable opportunities for gene synthesis companies. However, the market faces challenges due to a shortage of skilled professionals, prompting businesses to partner with educational institutions for training initiatives to cultivate necessary talent.

Top-down and bottom-up approaches were used to estimate and validate the size of the Gene Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Gene Synthesis Market Segments Analysis

Global Gene Synthesis Market is segmented by method, service, application, end use and region. Based on method, the market is segmented into solid-phase synthesis, chip-based synthesis and PCR-based enzyme synthesis. Based on service, the market is segmented into antibody DNA synthesis, viral DNA synthesis and others. Based on application, the market is segmented into vaccine development, therapeutics, diagnostics, research and development and synthetic biology. Based on end use, the market is segmented into academic and research institutes, biopharmaceutical companies and contract research organizations (CROs) and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Gene Synthesis Market

The gene synthesis market is propelled by its essential contributions across multiple domains, including molecular biology, genetic engineering, drug discovery, and synthetic biology. This technology facilitates in-depth exploration of gene functions, the creation of genetically modified organisms, and the development of innovative therapeutic solutions. Additionally, it supports the engineering of new biological systems, broadening the horizon for scientific inquiry and application. As the utility of gene synthesis continues to expand within research and development endeavors, its growing significance fuels an increase in market demand, reflecting its integral role in advancing various biotechnological and medical innovations.

Restraints in the Gene Synthesis Market

The gene synthesis market faces significant challenges due to ethical considerations surrounding the potential misuse of synthesized genetic material, which could enable the creation of harmful pathogens or organisms. These ethical issues necessitate robust regulatory frameworks aimed at mitigating risks, ensuring that the industry operates within defined safety parameters. However, the stringent nature of these regulations can impose limitations on market growth, particularly regarding the process of securing necessary approvals and licenses for various applications. Consequently, while regulatory compliance is essential for maintaining safety and ethical standards, it can also restrict innovation and expansion within the gene synthesis sector.

Market Trends of the Gene Synthesis Market

The gene synthesis market is experiencing notable growth driven by the escalating demand for gene editing and gene therapy innovations, particularly through the application of advanced technologies such as CRISPR-Cas9. As researchers and biotech companies increasingly focus on developing precise genetic modifications, the need for customized DNA constructs becomes critical. This trend highlights the essential role gene synthesis plays in facilitating breakthroughs in gene therapies and personalized medicine. Additionally, the amplified interest in these cutting-edge technologies is fostering a competitive landscape within the gene synthesis industry, motivating companies to enhance their service offerings and innovate their processes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Patent Analysis
Case Studies

Global Gene Synthesis Market Size by Method & CAGR (2026-2033)

Market Overview
Solid-Phase Synthesis
Chip-Based Synthesis
PCR-Based Enzyme Synthesis

Global Gene Synthesis Market Size by Service & CAGR (2026-2033)

Market Overview
Antibody DNA Synthesis
Viral DNA Synthesis
Others

Global Gene Synthesis Market Size by Application & CAGR (2026-2033)

Market Overview
Vaccine Development
Therapeutics
Diagnostics
Research And Development
- Academic Research
- Industrial Research
Synthetic Biology
- Pathway Engineering
- Genome Engineering

Global Gene Synthesis Market Size by End Use & CAGR (2026-2033)

Market Overview
Academic And Research Institutes
Biopharmaceutical Companies
Contract Research Organizations (CROs)

Global Gene Synthesis Market Size & CAGR (2026-2033)

North America (Method, Service, Application, End Use)
- USA
- Canada
Europe (Method, Service, Application, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Method, Service, Application, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Method, Service, Application, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Method, Service, Application, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Thermo Fisher Scientific Inc. (GeneArt)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Genomics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integrated DNA Technologies (IDT)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Twist Bioscience
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ATUM
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio Basic Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SBS Genetech Co. Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Azenta Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OriGene Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioneer Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genewiz
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Blue Heron Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Biogene
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGI-DNA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments